Vectus Biosystems: Half Year Report
Filed with ASX · · 20 pages · English
28 February 2020 Company Announcements Office Australian Securities Exchange Vectus Biosystems Limited (Vectus or the Company) reports its financial results for the half-year ended 31 December 2019. The Vectus Group’s operating costs continue to be carefully controlled, with a small decrease compared to the prior corresponding period, down from $1.41 million in the 2018 half year to $1.39 million
Vectus Biosystems Limited on 6ix
Earlier from Vectus Biosystems
- Appendix 4C - quarterly
- Response to ASX Price Query
- Convertible Note Issue
- Preliminary Final Report Appendix 4E
- Response to Appendix 4C Query
Later from Vectus Biosystems
- Appendix 4C - Quarterly Report
- Quarterly Activities Report and Appendix 4C
- Proposed issue of Securities - VBS
- Vectus completes $7 million placement
- Approval Received for Phase I Trial in Australia
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems